Alive Technologies Pty. Ltd.

Background

The Alive Technologies Monitoring System meets an existing need that has not been satisfied by any product currently available.

The product is targeted to the diagnosis and treatment of chronic cardiovascular diseases, including atrial fibrillation, congestive heart failure and sleep apnea, as well as general health and fitness. Congestive heart failure alone affects over 3 million Americans leading to over 2.5 million hospital admissions annually at a cost of US$7.5 billion. Each year, 400,000 new cases are diagnosed. Researchers expect the incidence of congestive heart failure to double by the year 2020. By having appropriate diagnostic and monitoring systems suitable for primary care and home use as proposed by Alive Technologies, hospital admissions will be considerably reduced, and the disease diagnosed and treated at an early stage, preventing its progression.

Source: American Heart Association, 28/07/2003	Source: American Journal of Epidemiology Vol. 155, No. 9, 2002
Source: The Journal of American Medicine, Volume 285, 2001	Source: American Heart Association, 2003 Update

The treatment of patients with chronic illness in their own home will be greatly improved. Because the Alive Monitor sends out data wirelessly, patient health can be monitored continuously while patients are leading their normal life. The patient’s quality of life will be improved, and the patient’s condition more easily diagnosed.

Projected burden of congestive heart failure in Scotland from 2000 to 2020

Source: Heart, Volume 89, 2003

Hospitalization Rates for Congestive Heart Failure (USA)

Source: National Heart, Lung and Blood Institute, Chart Book 2002